نتائج البحث - "Joanne Lager"

1

Supplementary Figure S1 from Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma

المؤلفون: Farrukh T. Awan, Coumaran Egile, Jason Jiang, Joanne Lager, Siddha N. Kasar, Pau Abrisqueta, Jordi Rodon, Matthew S. Davids, Jennifer R. Brown

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b315da444187cd4aff9dc970ff69dc60
https://doi.org/10.1158/1078-0432.22458534.v1

2

Data from Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma

المؤلفون: Farrukh T. Awan, Coumaran Egile, Jason Jiang, Joanne Lager, Siddha N. Kasar, Pau Abrisqueta, Jordi Rodon, Matthew S. Davids, Jennifer R. Brown

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b91ee4aa6fe8ef7db742f04311081c8
https://doi.org/10.1158/1078-0432.c.6523983.v1

3

Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

المصدر: Cancer Cell

مصطلحات موضوعية: Messenger RNA, Antitumor immunity, business.industry, medicine.medical_treatment, RNA, Neoplasms therapy, General Medicine, Immunotherapy, Article, Immune system, Neoplasms, Cancer research, Systemic administration, Cytokines, Humans, Medicine, RNA, Messenger, business, Gene

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ad00a44220c5d4522fd2289ce47795
https://doi.org/10.1126/scitranslmed.abc7804

4

TIG-007: Study of EOS884448/GSK4428859A Alone, and in Combination with Iberdomide with or without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma

المؤلفون: Yvonne McGrath, Philippe Moreau, Geoffrey R. Hill, Joanne Lager, Philippa Graham, Gregory Driessens, Olivier De Henau, Nathalie Meuleman, Leona Holmberg

المصدر: Blood. 138:2745-2745

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, Immunology, medicine, Refractory Multiple Myeloma, Cell Biology, Hematology, business, Biochemistry, Dexamethasone, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::15db1633cacbd8da1c35d64e1378416b
https://doi.org/10.1182/blood-2021-152395

5

Abstract CT118: Preliminary data from Phase I first-in-human study of EOS884448, a novel potent anti-TIGIT antibody, monotherapy shows favorable tolerability profile and early signsof clinical activity in immune-resistant advanced cancers

المؤلفون: Sylvie Rottey, Servane Warot, Joanne Lager, Jean-Pascal Machiels, Thi Lien-Anh Nguyen, Gregory Driessens, Clarise Truong, Christiane Jungels, Ariane Migeotte, Brant Delafontaine, Olivier De Henau, Tom F.A. Van den Mooter

المصدر: Cancer Research. 81:CT118-CT118

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Cancer, medicine.disease, Clinical trial, TIGIT, Pharmacokinetics, Tolerability, Pharmacodynamics, Internal medicine, biology.protein, Medicine, Antibody, business, Adverse effect

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::852f804b3f66274d905439bd0a47c825
https://doi.org/10.1158/1538-7445.am2021-ct118

6

Phase 1 trial of the adenosine A2A receptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A2A receptor within the tumor

المؤلفون: Johann S. de Bono, Maura Rossetti, Jean-Pascal Machiels, Noémie Wald, Esha A. Gangolli, Joanne Lager, Erol Wiegert, Thubeena Manickavasagar, Nicola McIntyre, Chiara Martinoli, Ariane Migeotte, Laurence Buisseret, Sylvie Rottey, Brant Delafontaine

المصدر: Journal of Clinical Oncology. 39:2562-2562

مصطلحات موضوعية: Antitumor activity, Cancer Research, business.industry, Antagonist, Adenosine A2A receptor, Pharmacology, Adenosine, Immune system, Oncology, Tolerability, Extracellular, Medicine, business, Receptor, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b080dd836a7785e87d2848defe58b9bc
https://doi.org/10.1200/jco.2021.39.15_suppl.2562

7

Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors

المؤلفون: Geoffrey I. Shapiro, Sara M. Tolaney, Joseph Pearlberg, Carlos L. Arteaga, Daniel C. Cho, Nicole G. Chau, Vandana G. Abramson, Tarah J. Ballinger, Joanne Lager, John Hilton, Jeffrey G. Supko, James M. Cleary

المصدر: Clinical Cancer Research. 23:3520-3528

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Receptor, ErbB-3, Side effect, Class I Phosphatidylinositol 3-Kinases, Pharmacology, Antibodies, Monoclonal, Humanized, Gastroenterology, Loading dose, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Neoplasms, Quinoxalines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Aged, Sulfonamides, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, Cancer, Middle Aged, medicine.disease, Antibodies, Neutralizing, Rash, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Pharmacodynamics, Mutation, Monoclonal, Toxicity, Female, medicine.symptom, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0162ab14e38800125ecf2b30109aef5a
https://doi.org/10.1158/1078-0432.ccr-16-1764

8

Phase Ib trial of the PI 3K/ mTOR inhibitor voxtalisib ( SAR 245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B‐cell malignancies

المؤلفون: Lia Gore, Jyoti Sharma, Luciano J. Costa, Farrukh T. Awan, Lei Gao, Joanne Lager

المصدر: British Journal of Haematology. 175:55-65

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::de4dd0ac82605de37373d1acbeafe675
https://doi.org/10.1111/bjh.14181

View record at Wiley

9

Multiplex IHC panel development for adenosine pathway markers and TIL in human cancer specimens

المؤلفون: M. Detheux, Noémie Wald, Soizic Garaud, O. De Henau, Marjorie Mercier, Veronique Bodo, Céline Naveaux, Anaïs Boisson, A. Vezzu, Karen Willard-Gallo, Joanne Lager, E. Houthuys, A. Pabois, S. Crosignani, Chiara Martinoli, N. Thomas

المصدر: Annals of Oncology. 30:xi51

مصطلحات موضوعية: CD20, Tumor microenvironment, biology, business.industry, Cancer, FOXP3, Hematology, medicine.disease, Cytokeratin, Immune system, Oncology, Cancer research, biology.protein, Medicine, Immunohistochemistry, Antibody, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a4c8649bf838c4c48dda385568b743e7
https://doi.org/10.1093/annonc/mdz452.010

10

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

المساهمون: Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Hematology

المصدر: Lancet. Haematology, 5(4), e170-e180. Lancet Publishing Group
Lancet Haematology, 5(4), E170-E180. Lancet Publishing Group

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8e3e355700dce3555f9c690f5ec710
https://pubmed.ncbi.nlm.nih.gov/29859612

View record from ScienceDirect

Full Text via ClinicalKey

تنقيح النتائج